Bradley L. Radoff and Michael Torok (together with certain of their affiliates, the "Radoff-JEC Group" or "we"), who collectively own approximately 7.6% of the outstanding shares of Seer, Inc. (NASDAQ ...

Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that it will report financial results for the first quarter 2026 on Wednesday, May 13, ...

(Nasdaq: SEER) (“Seer” or the “Company”), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that its Board of Directors (the “Board”) has thoroughly reviewed and ...

Seer (SEER) gets a raised $2.35/share cash takeover bid from Radoff-JEC plus a contingent value right and May 2 deadline.

-Advancing pipeline of first-in-class liquid biopsy products with the goal of detecting diseases at early, pre-symptomatic stages- SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Seer, Inc., launched ...

(Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that its Proteograph ® Product Suite, has been selected as the mass spectrometry-based proteomic ...

Seer's board has rejected an upgraded offer by minority shareholders Bradley Radoff and Michael Torok to take the company private. The biotechnology company on Monday said that the board has ...

“When you’re waiting for the elevator, you might as well pick up a card to make someone feel seen,” says Wil Reynolds, 45, Seer’s bootstrapping founder and CEO–a man who’s led the company to seven ...